Understanding pressurized metered dose inhaler performance

Bibliography

• Thiel CG. From Susie’s question to CFC free: an inventor’s perspective on forty years of MDI development and regulation. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery V. Interpharm Press, Buffalo Grove, IL; 1996. p. 115-24
   Google Scholar
• Lechuga-Ballesteros D, Noga B, Vehring R, et al. Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma. Future Med Chem 2011;3(13):1703-18
   PubMed Web of Science ®Google Scholar
• Stein S, Sheth P, Hodson PD, et al. Advances in metered dose inhaler technology: hardware development. AAPS PharmSciTech 2014;15(2):326-38
   PubMed Web of Science ®Google Scholar
• Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech 2014;15(2):434-55
   PubMed Web of Science ®Google Scholar
• Darquenne C. Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv 2012;25(3):140-7
   PubMed Web of Science ®Google Scholar
• Mitchell J, Newman S, Chan H-K. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. AAPS PharmSciTech 2007;8(4):237-48
   Web of Science ®Google Scholar
• Son Y-J, Mitchell JP, McConville JT. In vitro performance testing for pulmonary drug delivery. In: Smyth HDC, Hickey AJ, editors. Controlled pulmonary drug delivery. Springer; New York; 2011. p. 383-415
   Google Scholar
• Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd edition. Wiley, Hoboken, NJ; 1999
   Google Scholar
• Chapter 601: Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers. In: United states pharmacopeia and national formulary (USP 36 – NF 31). United Book Press, Baltimore, MD; 2013
   Google Scholar
• Mitchell JP, Copley M, Solomon D. Applying the AIM concept in support of developing improved in vitro-in vivo relationships for OIPs. In: Tougas TP, Mitchell JP, Lyapustina SA, editors. Good cascade impactor practices, AIM and EDA for orally inhaled products. Springer Science & Business Media, New York; 2013. p. 375-400
   Google Scholar
• Vervaet C, Byron PB. Drug-surfactant-propellant interactions in HFA formulations. Int J Pharm 1999;186:13-30
   PubMed Web of Science ®Google Scholar
• Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet 2011;377(9770):1032-45
   PubMed Web of Science ®Google Scholar
• Stein S, Fradley G. What is the future of MDIs? In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery 2010. Virginia Commonwealth University, Richmond, VA; Volume 2 2010. p. 373-6
   Google Scholar
• Newman SP. Principles of metered-dose inhaler design. Respir Care 2005;50(9):1177-90
   PubMedGoogle Scholar
• Lewis DA, O’Shea H, Johnson R, et al. Predicting HFA-MDI dose retention properties: engineering the marriage between canisters, valves and formulations. In: Dalby RN, Byron PR, Peart J, et al. editors. RDD Europe 2011. Virginia Commonwealth University, Richmond, VA; 2011. p. 89-100
   Google Scholar
• Roth C, Gebhart J. Aqueous droplet sizing by inertial classification. Particle Particle Syst Charact 1996;13(3):192-5
   Web of Science ®Google Scholar
• Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J Aerosol Med 2003;16(2):167-74
   PubMedGoogle Scholar
• Lewis DA, Ganderton D, Meakin BJ, et al. Modulite ® : a simple solution to a difficult problem. Respiration 2005;72(Suppl 1):3-5
   PubMedGoogle Scholar
• Lewis D, Young P, Buttini F, et al. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient. Eur J Pharm Biopharm 2014;86:31-7
   PubMed Web of Science ®Google Scholar
• Dellamary LA, Tarara TE, Smith DJ, et al. Hollow porous particles in metered dose inhalers. Pharm Res 2000;17(2):168-74
   PubMed Web of Science ®Google Scholar
• Tarara TE, Hartman MS, Gill H, et al. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a. Pharm Res 2004;21(9):1607-14
   PubMed Web of Science ®Google Scholar
• Vehring R, Lechuga-Ballesteros D, Joshi V, et al. Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers. Langmuir 2012;28:15015-23
   PubMed Web of Science ®Google Scholar
• Noga B, Cummings RH, Joshi V, et al. Product performance, stability and dose proportionality of glycopyrrolate metered dose inhaler with sub-microgram doses using cosuspension technology. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory Drug Delivery 2012. Davis Healthcare International Publishing, River Grove; 2012. p. 645-8
   Google Scholar
• James J, Crean B, Davies M, et al. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers. Int J Pharm 2008;361:209-21
   PubMed Web of Science ®Google Scholar
• Lewis D, Ganderton D, Meakin B, et al. Theory and practice with solution systems. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery IX. Davis Healthcare International, River Grove, IL; 2004. p. 109-15
   Google Scholar
• Tam JM, Engstrom JD, Ferrer D, et al. Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers. J Pharm Sci 2010;99(7):3150-65
   PubMed Web of Science ®Google Scholar
• Weers J, Tarara T. The Pulmosphere™ platform for pulmonary drug delivery. Ther Deliv 2014;5(3):277-95
   PubMedGoogle Scholar
• Smyth HD. Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin Drug Deliv 2005;2(1):53-74
   PubMedGoogle Scholar
• Conner JB, Buck PO. Improving asthma management: the case for mandatory inclusion of dose counters on all rescue bronchodilators. J Asthma 2013;50(6):658-63
   PubMed Web of Science ®Google Scholar
• O’Donnell KP, Williams ROIII. Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability. Drug Dev Ind Pharm 2013;39(3):413-24
   PubMed Web of Science ®Google Scholar
• Rogueda P. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opin Drug Deliv 2005;2(4):625-38
   PubMedGoogle Scholar
• Javaheri E, Finlay WH. Numerical simulation of flocculation and transport of suspended particles: application to metered-dose inhalers. Int J Multiphase Flow 2014;64:28-34
   Web of Science ®Google Scholar
• Wu ZZ, Thatcher ML, Lundberg JK, et al. Forced degradation studies of corticosteroids with an alumina – steroid – ethanol model for predicting chemical stability and degradation products of pressurized metered-dose inhaler formulations. J Pharm Sci 2012;101(6):2109-22
   PubMed Web of Science ®Google Scholar
• Young PM, Price R, Lewis D, et al. Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope. J Colloid Interface Sci 2003;262(1):298-302
   PubMed Web of Science ®Google Scholar
• Smith IJ, Bell J, Bowman N, et al. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv 2010;23(Suppl 2):S25-37
   PubMedGoogle Scholar
• Dohmeier D, Heyworth D, Wilde T. The application of a new high performance dual-layer coating to pressurized metered dose inhaler hardware. In: Dalby RN, Byron PR, Peart J, et al. editors. RDD Europe 2009. Virginia Commonwealth University, Richmond, VA; 2009. p. 209-12
   Google Scholar
• Stein S, Forsyth B, Stefely J, et al. Expanding the dosing range of metered dose inhalers through formulation and hardware optimization. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery IX. Virginia Commonwealth University, Richmond, VA; 2004. p. 125-34
   Google Scholar
• Lewis D, Meakin B, Brambilla G. New actuators versus old: reasons and results for actuator modifications for HFA solution MDIs. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery 2006. Virginia Commonwealth University, Richmond, VA; 2006. p. 101-10
   Google Scholar
• Versteeg H, Hargrave G. Near-orifice spray and valve flow regime of a pharmaceutical pressurised metered dose inhaler. Proc. ILASS 2002. 2002;167-71. Available from: http://www.ilasseurope.org/ICLASS/ilass2002/papers/076.pdf
   Google Scholar
• Vehring R, Finlay W. State of the field: manufacturing and device options for the delivery of biotherapeutics. J Aerosol Med Pulm Drug Deliv 2013;26:A9
   Google Scholar
• Schultz RK. Drug delivery characteristics of metered-dose inhalers. J Allergy Clin Immunol 1995;96(2):284-7
   PubMed Web of Science ®Google Scholar
• Cummings RH. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition – valve performance. J Allergy Clin Immunol 1999;104(6):s230-s35
   PubMed Web of Science ®Google Scholar
• Church T, Hargrave G, Johnson R, et al. Visualising dose retention: effects of temperature fluctuation on a pMDI capillary retention model. In: Dalby RN, Byron PR, Peart J, et al. editors. RDD Europe 2011. Virginia Commonwealth University, Richmond, VA; 2011. p. 317-20
   Google Scholar
• Cyr TD, Graham SJ, Li KR, Levering EG. Low first-spray drug content in albuterol metered-dose inhalers. Pharm Res 1991;8(5):658-60
   PubMed Web of Science ®Google Scholar
• Fradley G, Hodson D. Optimization of fluid flow in pMDI valves. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery 2008. Virginia Commonwealth University, Richmond, VA; 2008. p. 329-32
   Google Scholar
• Colombani A, Chambers F, Lee K, et al. Understanding the cause of increasing dose through life from a pressurised metered dose inhaler (pMDI). J Pharm Pharmacol 2010;62(10):1314-15
   Web of Science ®Google Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 2010;392:1-19
   PubMed Web of Science ®Google Scholar
• Cheng Y-S, Zhou Y, Chen BT. Particle deposition in a cast of human oral airways. Aerosol Sci Technol 1999;31(4):286-300
   Web of Science ®Google Scholar
• Stein SW. Estimating the number of droplets and drug particles emitted from MDIs. AAPS PharmSciTech 2008;9(1):112-15
   PubMed Web of Science ®Google Scholar
• Stein SW. Aiming for a moving target: challenges with impactor measurements of MDI aerosols. Int J Pharm 2008;355(1):53-61
   PubMedGoogle Scholar
• Clark A. The physics of aerosol formation by MDIs: limitations of the current approach. J Biopharm Sci 1992;3(1):69-76
   Google Scholar
• Clark AR. Metered atomisation for respiratory drug delivery [PhD thesis]. Loughborough University of Technology, Loughborough, UK; 1991
   Google Scholar
• Hochrainer D, Hölz H, Kreher C, et al. Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalers. J Aerosol Med 2005;18(3):273-82
   PubMedGoogle Scholar
• Crosland BM, Johnson MR, Matida EA. Characterization of the spray velocities from a pressurized metered-dose inhaler. J Aerosol Med Pulm Drug Deliv 2009;22(2):85-98
   PubMed Web of Science ®Google Scholar
• Finlay WH. The mechanics of inhaled pharmaceutical aerosols. Academic Press, San Diego; 2001
   Google Scholar
• Finlay W. Pharmaceutical aerosol sprays for drug delivery to the lungs. In: Ashgriz N, editor. Handbook of atomization and sprays: theory and applications. Springer, New York, 2011. p. 899-907
   Google Scholar
• Dunbar C, Watkins A, Miller J. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med 1997;10(4):351-68
   PubMedGoogle Scholar
• Dunbar C, Miller J. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Sprays 1997;7(4):417-36
   Web of Science ®Google Scholar
• Dunbar C. Atomization mechanisms of the pressurized metered dose inhaler. Particulate Sci Technol 1997;15(3-4):253-71
   Web of Science ®Google Scholar
• Versteeg H, Hargrave G, Kirby M. Internal flow and near-orifice spray visualisations of a model pharmaceutical pressurised metered dose inhaler. J Phys Conf Ser 2006;45:207
   Google Scholar
• Versteeg HK, Hargrave G. Fundamentals and resilience of the original MDI actuator design. In: Dalby RN, Byron PR, Peart J, et al. editors. respiratory drug delivery 2006. Virginia Commonwealth University, Richmond,VA; 2006. p. 91-100
   Google Scholar
• Bayvel L, Orzechowski Z. Liquid atomization. Taylor & Francis, London; 1993
   Google Scholar
• Wigley G, Versteeg H, Hodson D. Near-orifice PDA measurements and atomisation mechanism of a pharmaceutical pressurised metered dose inhaler. Proc ILASS 2002. 2002. Available from: http://www.ilasseurope.org/ICLASS/ilass2002/papers/029.pdf
   Google Scholar
• Liu X, Doub WH, Guo C. Evaluation of metered dose inhaler spray velocities using phase doppler anemometry (PDA). Int J Pharm 2012;423(2):235-9
   PubMedGoogle Scholar
• Ivey JW, Lewis D, Church T, et al. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers. Int J Pharm 2014;465(1):18-24
   PubMed Web of Science ®Google Scholar
• DeCarlo PF, Slowik JG, Worsnop DR, et al. Particle morphology and density characterization by combined mobility and aerodynamic diameter measurements. Part 1: theory. Aerosol Sci Technol 2004;38(12):1185-205
   Web of Science ®Google Scholar
• Grainger C, Saunders M, Buttini F, et al. Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence. Mol Pharm 2012;9(3):563-9
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Nagel MW, Wiersema KJ, et al. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech 2003;4(4):425-33
   Google Scholar
• Meakin B, Lewis D, Ganderton D, et al. Countering challenges posed by mimicry of CFC performance using HFA systems. In: Dalby RN, Byron PR, Farr SJ, et al. editors. Respiratory drug delivery VII. Serentec, Raleigh, NC; 2000. p. 99-108
   Google Scholar
• Brambilla G, Ganderton D, Garzia R, et al. Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int J Pharm 1999;186(1):53-61
   PubMed Web of Science ®Google Scholar
• Lewis DA. Intrinsic particle size distribution: a new metric to guide the design of HFA solution pMDIs. In: Dalby RN, Byron PR, Peart J, et al. editors. RDD Europe 2013. Virginia Commonwealth University, Richmond, VA; 2013. p. 175-84
   Google Scholar
• Stein SW, Myrdal PB. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J Pharm Sci 2004;93(8):2158-75
   PubMed Web of Science ®Google Scholar
• Clark AR. MDIs: physics of aerosol formation. J Aerosol Med 1996;9(Suppl 1):S19-26
   PubMedGoogle Scholar
• Nikander K. Challenges and opportunities in respiratory drug delivery devices. Expert Opin Drug Deliv 2010;7(11):1235-8
   PubMed Web of Science ®Google Scholar
• Buchmann NA, Duke DJ, Shakiba SA, et al. A novel high-speed imaging technique to predict the macroscopic spray characteristics of solution based pressurised metered dose inhalers. Pharm Res 2014;31:2963-74
   PubMed Web of Science ®Google Scholar
• Cheng YS. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract. AAPS PharmSciTech 2014;15(3):630-40
   PubMed Web of Science ®Google Scholar
• Fuchs NA. Evaporation and droplet growth in gaseous media. Pergamon Press, London; 1959
   Google Scholar
• Brambilla G, Church T, Lewis D, et al. Plume temperature emitted from metered dose inhalers. Int J Pharm 2011;405(1):9-15
   PubMedGoogle Scholar
• Martin AR, Finlay WH. The effect of humidity on the size of particles delivered from metered-dose inhalers. Aerosol Sci Technol 2005;39:283-9
   Web of Science ®Google Scholar
• Saleem IY, Smyth HD. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants. BioMed Res Int 2013. 2013:574310
   Google Scholar
• Callingham M. A statistical model for predicting the particle distribution of an atomised powder in liquid mixture. Int J Cosmet Sci 1980;2:107-26
   PubMed Web of Science ®Google Scholar
• Ivey J, Vehring R. The use of modeling in spray drying of emulsions and suspensions accelerates formulation and process development. Comput Chem Eng 2010;34(7):1030-5
   Google Scholar
• Stein SW, Sheth P, Myrdal PB. A model for predicting size distributions delivered from pMDIs with suspended drug. Int J Pharm 2012;422(1):101-15
   PubMedGoogle Scholar
• Sheth P, Stein SW, Myrdal PB. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers. Int J Pharm 2013;455(1–2):57-65
   PubMed Web of Science ®Google Scholar
• Sheth P, Stein SW, Myrdal PB. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers. AAPS PharmSciTech 2014; Online ISSN: 1530-9932; 10.1208/s12249-014-0210-z
   Web of Science ®Google Scholar
• Zhu B, Traini D, Lewis DA, et al. The solid-state and morphological characteristics of particles generated from solution-based metered dose inhalers: influence of ethanol concentration and intrinsic drug properties. Colloid Surf A Physicochem Eng Aspects 2014;443:345-55
   Web of Science ®Google Scholar
• Sheth P, Fazel M, Stein SW, et al. Formulation effects on differential throat deposition for pMDIs with USP inlet and Alberta idealized throat. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery 2014. Volume 3 Virginia Commonwealth University, Richmond, VA; 2014. p. 631-6
   Google Scholar
• Zhu B, Xu N, Traini D, et al. The effect of temperature on particles delivered by metered dose inhalers. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery 2014. Volume 3 Virginia Commonwealth University, Richmond, VA; 2014. p. 793-6
   Google Scholar
• Haynes A, Shaik MS, Krarup H, et al. Evaluation of the Malvern Spraytec® with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J Pharm Sci 2004;93(2):349-63
   PubMed Web of Science ®Google Scholar
• Stein SW, Myrdal PB. The relative influence of atomization and evaporation on metered dose inhaler drug delivery efficiency. Aerosol Sci Technol 2006;40(5):335-47
   Web of Science ®Google Scholar
• Gabrio BJ, Stein SW, Velasquez DJ. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 1999;186:3-12
   PubMed Web of Science ®Google Scholar
• Ganderton D, Lewis D, Davies R, et al. Modulite®: a means of designing the aerosols generated by pressurized metered dose inhalers. Respir Med 2002;96:S3-8
   PubMed Web of Science ®Google Scholar
• McFadden Jr E. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995;96(2):278-83
   PubMed Web of Science ®Google Scholar
• Dunbar CA, Hickey AJ. pMDI optimization using an actuator flow model. In: Dalby RN, Byron PR, Farr SJ, et al. editors. Respiratory drug delivery VI. Interpharm Press, Buffalo Grove, IL; 1998. p. 319-22
   Google Scholar
• Newman S, Moren F, Pavia D, et al. The effects of changes in metered volume and propellant vapour pressure on the deposition of pressurized inhalation aerosols. Int J Pharm 1982;11(4):337-44
   Web of Science ®Google Scholar
• Wilson AF, Mukai DS, Ahdout JJ. Effect of canister temperature on performance of metered-dose inhalers. Am Rev Respir Dis 1991;143:1034-7
   PubMed Web of Science ®Google Scholar
• Stein SW, Cocks P. Size distribution measurements from metered dose inhalers at low temperatures. In: Dalby RN, Byron PR, Peart J, et al. editors. RDD Europe 2013. Virginia Commonwealth University, Richmond, VA; 2013
   Google Scholar
• Morin CM, Ivey JW, Titosky JT, et al. Performance of pressurized metered dose inhalers at extreme temperature conditions. Pharm Res 2014;103(11):3553-9
   Google Scholar
• Lange CF, Finlay WH. Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med 2000;161(5):1614-18
   PubMed Web of Science ®Google Scholar
• Martin AR, Kwok DY, Finlay WH. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments. J Aerosol Med 2005;18(2):218-24
   PubMedGoogle Scholar
• Shemirani FM, Hoe S, Lewis D, et al. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs. J Aerosol Med Pulm Drug Deliv 2013;26(4):215-22
   PubMed Web of Science ®Google Scholar
• Shrubb I. Influence of throat coating and flow rate on usp throat deposition. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery VI. Interpharm Press, Buffalo Grove, IL; 1998. p. 413-16
   Google Scholar
• Rahmatalla MF, Zuberbuhler PC, Lange CF, et al. In vitro effect of a holding chamber on the mouth-throat deposition of QVAR® (hydrofluoroalkane-beclomethasone dipropionate). J Aerosol Med 2002;15(4):379-85
   PubMedGoogle Scholar
• Hoe S, Traini D, Chan H-K, et al. The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers. Pharm Res 2009;26(12):2639-46
   PubMed Web of Science ®Google Scholar
• Stein SW, Gabrio BJ. Understanding throat deposition during cascade impaction testing. In: Dalby RN, Byron PR, Farr SJ, et al. editors. Respiratory drug delivery VII. Serentec Press, Raleigh, NC; 2000. p. 287-90
   Google Scholar
• Longest PW, Hindle M. Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths. J Aerosol Med Pulm Drug Deliv 2009;22(3):271-83
   PubMed Web of Science ®Google Scholar
• Kelkar MS, Dalby RN. Effervescent aerosols: a novel formulation technology for pressurized metered dose inhalers. In: Dalby RN, Byron PR, Peart J, et al. editors. Respiratory drug delivery 2014. Volume 3 Virginia Commonwealth University, Richmond, VA; 2014. p. 669-72
   Google Scholar